Back to RecallTracker
Health Canada Health products

JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules

Issued May 5, 2025
Issue
Affected lot (JAMP-Pregabalin 50mg) may contain capsule(s) of JAMP-Pregabalin 150mg.
Hazard description
Product safety
What to do
Check your medication bottle to ensure it only contains 50 mg capsules. The 50 mg capsule is white with “PG” and “50” printed on it in black ink. The 150 mg capsule is white with “PG” and “150” printed on it in black ink. If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement, if needed. If you are unable to return your capsules to the pharmacy right away, talk to your pharmacist or doctor for further guidance. Seek immediate medical attention if you are experiencing symptoms of an overdose (e.g., confusion, agitation, restlessness and seizures). Do not stop taking pregabalin without first speaking to your doctor, as stopping abruptly may result in withdrawal symptoms. If you have questions about this recall, contact JAMP Pharma Corp. by calling 1-866-399-9091, extension 501, or by emailing custjamp@jamppharma.com . Report any health product-related side effects or complaints to Health Canada.
Product
Product name
JAMP-Pregabalin
Reference
ID
RA-77402